Epsy Health

What Epsy Health does

Epsy Health is a digital health platform focused on epilepsy self-management, operating as a brand and subsidiary of LivaNova USA, Inc. — a publicly traded medical technology company (NASDAQ: LIVN) specializing in neuromodulation and cardiovascular solutions. Founded in 2020 by Marco Peluso and headquartered in Houston, Texas (100 Cyberonics Boulevard, the LivaNova USA headquarters), the platform serves people living with epilepsy, their caregivers, and healthcare providers. The core product is the Epsy mobile application, available on iOS since April 2020 and Android since July 2020, which allows users to log seizures, auras, medications, side effects, and triggers; receive medication reminders; view insights and trends from logged data; and generate downloadable doctor's reports for clinical appointments. A companion product, Epsy Hub (launched September 2020), gives clinicians a window into patient-generated data during consultations.

The underlying technology is a cross-platform mobile application with native integrations to Apple Watch, Apple HealthKit, and Google Fit for cross-device health data synchronization. An interactive Drug-Resistant Epilepsy (DRE) screening quiz identifies the approximately one-third of epilepsy patients whose seizures remain uncontrolled by medication and routes them toward information on alternative treatments — directly aligned with LivaNova's neuromodulation product portfolio. The platform maintains documented compliance with COPPA (for pediatric users), the California Consumer Privacy Act (CCPA), and the Nevada Consumer Health Data Privacy Law and Washington My Health My Data Act, indicating a deliberate multi-jurisdiction posture for handling sensitive health data of both adults and minors.

Epsy's business model is freemium with a fully free consumer tier: the mobile application is offered at no cost, with no disclosed paid tiers, subscriptions, or premium feature gating. Distribution is product-led through Apple App Store and Google Play for global reach, supported by a content-driven go-to-market strategy encompassing a journey-segmented blog, community user stories, email newsletter, and social media presence across Facebook, X, Instagram, and LinkedIn. Pricing signals are not disclosed at the entity level and revenue is not publicly reported; Epsy functions primarily as a patient engagement and education layer inside LivaNova's epilepsy franchise, against an addressable population of roughly 3.4 million diagnosed epilepsy patients in the United States and 65 million globally.

Name

Epsy Health

Legal name

LivaNova USA, Inc.

Website

https://epsyhealth.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Epsy Health is a digital health platform and free mobile application for epilepsy self-management, providing seizure tracking, medication reminders, and clinician-ready reports to patients, caregivers, and healthcare providers, and operating as a subsidiary of LivaNova (NASDAQ: LIVN).

Ownership category

akta.pro rank

Product category

Digital Health / Epilepsy Management Software

akta.pro industry

PRIMARYHLACAOAB

eCOA/ePRO/eDiary & Patient-Facing Data Collection

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

SECONDARYHLALAIAG

Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)

Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms

Keywords

• Epilepsy management app
• Seizure tracking software
• Digital health platform
• Patient health monitoring
• Medication adherence app

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Mobile Application (Primary): Free consumer mobile application generating value through user engagement and data collection. Owned by LivaNova, a medical device company, suggesting potential data monetization or integration with LivaNova's neuromodulation products for epilepsy treatment.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Epsy Health operates a free mobile application (iOS and Android) that enables people with epilepsy and their caregivers to log seizures, auras, medications, side effects, and triggers, set medication reminders, view trend insights, and generate downloadable reports for doctors. It also offers Epsy Hub, a companion platform for healthcare providers to review patient data, alongside an educational content website and a Drug-Resistant Epilepsy (DRE) screening quiz.

Product overview

Epsy Health is a digital health platform focused on epilepsy management, consisting of the Epsy App (the core mobile application for iOS and Android), Epsy Hub (a companion platform for healthcare providers), and the Epsy website (educational content and community resources). The Epsy App enables users to track seizures, medications, side effects, and triggers; provides medication reminders; generates insights and trends; and produces downloadable doctor's reports. Epsy Hub allows doctors to review patient-generated data during appointments. The platform also includes educational blog content covering epilepsy topics, community stories, and a DRE (Drug Resistant Epilepsy) screening quiz. Epsy is owned and operated by LivaNova.

Differentiator

Problem solved

Functional benefit

Products and services

• Epsy App The primary mobile application for epilepsy management, allowing users to log seizures, auras, medications, side effects, and triggers; set medication reminders; view insights and trends; and generate downloadable doctor's reports. Available free on iOS and Android.
• Epsy Hub A companion platform for healthcare providers and doctors to review patient data, insights, and reports generated from the Epsy App during appointments.
• DRE Quiz An interactive quiz tool to help users identify if they may have Drug Resistant Epilepsy (DRE), directing them to relevant information and resources about alternative treatments.

Quantifiable outcome

• For people with DRE, medications don't work for approximately 1 in 3
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability1 record

Feature4 records

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Medisafe: Medication adherence and chronic-condition management app that helps patients track medications, receive reminders, and share reports with caregivers and providers — directly comparable to Epsy's medication-tracking and reminder functionality.
• Helpilepsy: Epilepsy self-management app focused on seizure logging, medication tracking, and clinician communication — a direct epilepsy-niche competitor to Epsy with overlapping feature set and target users.
• CareZone: Health management app with medication reminders, symptom tracking, and shared health journals for caregivers — overlapping with Epsy's tracking-and-reminder functionality and caregiver support positioning.
• Mango Health: Medication adherence app with reminders, tracking, and patient engagement mechanics — comparable to Epsy's core medication-reminder and adherence-tracking workflow in a chronic-disease context.
• MyTherapy: Patient-facing medication and symptom tracking app with reminders, health journals, and shareable reports — overlapping closely with Epsy's seizure/medication/side-effect logging and doctor-report features.
• SeizureTracker: Epilepsy-specific seizure logging and tracking platform used by patients and clinicians, directly competing in the same epilepsy-management niche as Epsy with longitudinal seizure diaries and clinical data sharing.

Broad incumbents

• Calm: Consumer digital wellness app with content addressing anxiety, sleep, and chronic stress — adjacent to Epsy's mental-health and caregiver-support positioning and competing for the same wellness-engaged chronic-condition users.
• MyChart (Epic): Dominant patient portal used by US health systems to surface EHR data, appointment info, and patient-reported data — competes with Epsy Hub for the clinician-facing workflow and represents an entrenched incumbent for patient-generated health data.
• Welldoc: Digital chronic disease management platform spanning diabetes, hypertension, and behavioral health with clinician integration — broader in scope than Epsy but operating in the same digital-therapeutic-for-chronic-condition category.
• Headspace Health: Digital mental health and wellness platform with employer/payer distribution — competes for the same chronic-condition consumer mindshare and overlaps with Epsy's mental-health content pillar.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/epsyhealth
• Facebookfacebook.com/EpsyApp
• LinkedInlinkedin.com/company/epsyhealth
• Instagraminstagram.com/epsyhealth

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Epsy Health